Clearfield fiscal 2025 net sales rise 20% to $150.1 million

Reuters
2025/11/25
Clearfield fiscal 2025 net sales rise 20% to $150.1 million

Clearfield Inc. reported net sales from continuing operations of $41.1 million for the fourth quarter of fiscal 2025, a 13% increase from $36.2 million in the prior year period. Gross margin improved from 26.6% to 34.6% year over year, attributed to higher volume, increased production efficiency, and lower excess inventory charges. Operating expenses for the quarter rose 10% to $13.3 million. Net income from continuing operations was $1.8 million, or $0.13 per diluted share, compared to a net loss of $0.05 million, or $(0.01) per diluted share, in the prior year quarter. For the full year ended September 30, 2025, net sales from continuing operations were $150.1 million, up 20% from $125.6 million in the previous year. The company also completed the divestiture of its European operations and focused investments on North American markets, with an order backlog of $24.7 million as of September 30, 2025. For the first quarter of fiscal 2026, Clearfield expects net sales from continuing operations in the range of $30 million to $33 million and net income (loss) per share between ($0.08) and $0.00.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearfield Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-25-007560), on November 25, 2025, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10